| 2025 |
Gao, Y., Laka, M., & Merlin, T. (2025). Does regulatory and reimbursement parallel processing provide swifter funded access to medicines for patients? Evaluation of cancer medicines using the Australian parallel process. Value in Health, 28(3), 431-440.
DOI |
| 2025 |
Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Ruanglertboon, W., Vitry, A., Gao, Y., . . . Hopkins, A. M. (2025). Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models. European Journal of Cancer, 218, 115274-1-115274-6.
DOI Scopus11 WoS10 Europe PMC6 |
| 2025 |
Gao, Y., Cheng, A., Li, L. X., Parent, N., Kichenadasse, G., Karapetis, C. S., . . . Sorich, M. J. (2025). Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial. International Journal of Cancer, 157(2), 336-344.
DOI Europe PMC1 |
| 2025 |
Carter, D., HASSAN, M., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2025). Engaging stakeholders along health technology assessment pathways: A scoping review of international practice. International Journal of Technology Assessment in Health Care, 41(1), e69-1-e69-9.
DOI |
| 2025 |
Li, L. X., Hopkins, A. M., Woodman, R., Abuhelwa, A. Y., Gao, Y., Parent, N., . . . Sorich, M. J. (2025). Discrimination, calibration, and variable importance in statistical and machine learning models for predicting overall survival in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors. Journal of Clinical Epidemiology, 112082.
DOI |
| 2025 |
Gao, Y., Li, L. X., Rowland, A., Karapetis, C. S., Parent, N., Kichenadasse, G., . . . Sorich, M. J. (2025). Progressive Lesion Type is Predictive of Post-progression Survival in First-line Chemoimmunotherapy for Non-small Cell Lung Cancer.. Cancer Letters, 218191.
DOI |
| 2023 |
Gao, Y., Laka, M., & Merlin, T. (2023). Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia. International Journal of Technology Assessment in Health Care, 39(1), e28-1-e28-9.
DOI Scopus5 WoS5 Europe PMC5 |
| 2023 |
Gao, Y., Laka, M., & Merlin, T. (2023). OP71 Road To Public Funding Of Cancer Codependent Technologies In Australia In The Last Ten Years. International Journal of Technology Assessment in Health Care, 39(S1), S19.
DOI |
| 2021 |
Gao, Y., Ju, X., & Jamieson, L. (2021). Associations between dental care approachability and dental attendance among women pregnant with an Indigenous child: a cross-sectional study. BMC Oral Health, 21(1), 451-1-451-10.
DOI Scopus3 WoS3 Europe PMC3 |
